AlisonRaeMoliternoMD
Hematology • Baltimore, MDAssociate Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Moliterno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-3142
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1989 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989
Certifications & Licensure
MD State Medical License 1992 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 266 citationsHuman-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disordersZhaohui Ye, Huichun Zhan, Prashant Mali, Sarah N. Dowey, Donna M. Williams
Blood. 2009-12-24 - 21 citationsThrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.C. John Sperati, Alison R. Moliterno
Hematology/oncology Clinics of North America. 2015-06-01 - 35 citationsJAK2 V617F allele burden in polycythemia vera: burden of proof.Alison R Moliterno, Hannah Kaizer, Brandi N Reeves
Blood. 2023-04-20
Abstracts/Posters
- Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational BurdenAlison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPNAlison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- ATM Germline Variant Increases the Risk of MPN ProgressionAlison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Independent Association of Male Sex with Presentation and Clinical Outcomes in Myeloproliferative Neoplasms2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans a...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Clinical and Community Connections in Saudi ArabiaJuly 28th, 2020
Grant Support
- Molecular Pathogenesis Of Polycythemia VeraNational Heart, Lung, And Blood Institute2005–2008
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/alison-moliterno
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
